My view of the stock hasn't changed. I didn't invest in RAP or MSB either.
I'm not saying Recell doesn't work. I am saying it isn't particularly compelling except perhaps where there there is a genuine shortage of skin donor sites, i.e a significant percentage of body surface area needs covering. And those cases are relatively uncommon. Most split skin grafts are relatively small.
Otherwise the extra cost is probably not worth it.
possibility of next institutional placement, page-12
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |